| 期刊全称 | Behavioral Pharmacology of Neuropeptides: Oxytocin | | 影响因子2023 | Rene Hurlemann,Valery Grinevich | | 视频video | | | 发行地址 | Gives insight into a new era of social psychopharmacology based on endogenous neuromodulators.Discusses early-life treatment of social-cognitive deficiencies.Provides cutting-edge information on "prec | | 学科分类 | Current Topics in Behavioral Neurosciences | | 图书封面 |  | | 影响因子 | .This volume collects cutting-edge expert reviews in the oxytocin field and will be of interest to a broad scientific audience ranging from social neuroscience to clinical psychiatry. The role of the neuropeptide oxytocin in social behaviors is one of the earliest and most significant discoveries in social neuroscience. Influential studies in animal models have delineated many of the neural circuits and genetic components that underlie these behaviors. These discoveries have inspired researchers to investigate the effects of oxytocin on brain and behavior in humans and its potential relevance as a treatment for psychiatric disorders including borderline personality disorder and autism and schizophrenia spectrum disorders. In fact, there is no established social psychopharmacology in Psychiatry, and oxytocin can be seen as the first endogenous agent specifically addressing social-cognitive impairment in psychiatric disorders, with animal research suggesting that it could be especiallyefficient in the early postnatal period. From a human perspective, it is crucial to understand more precisely who can benefit from potential oxytocin-related treatments, which outcome measures will best | | Pindex | Book 2018 |
The information of publication is updating
|
|
发表于 2025-3-21 18:26:51
